Henry Schein Inc. (HSIC) Stock

Henry Schein Inc. trades at a P/E ratio of 22.83, which is near the market average of approximately 20, suggesting the market views it as fairly valued relative to its earnings. Looking ahead, the forward P/E of 15.24 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 1.79 indicates reasonable value when growth is considered.

With a beta of 0.87, Henry Schein Inc. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 2.77 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Henry Schein Inc. achieves a profit margin of 3.21%, meaning it retains $3.21 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 5.75% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 8.47% and ROA at 4.61%, the company achieves moderate returns on invested capital.

Henry Schein Inc.'s revenue declined by 0.10% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. Earnings increased by 22.20% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES industry averages for proper context.

Henry Schein Inc. has a market capitalization of $9.16B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 125.00M shares outstanding, the company's ownership is relatively concentrated. As a participant in the WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES industry, it competes with other firms in this sector.

Henry Schein Inc.'s book value per share is $27.08, while the current stock price is $69.10, resulting in a price-to-book (P/B) ratio of 2.55. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

16 analysts cover HSIC with 38% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $76.35 implies 10.5% upside, but targets are often adjusted to follow price moves rather than predict them.

Current analyst recommendations:3 Strong Buy, 3 Buy, 9 Hold, 1 Sell, 0The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

RSI data is not available for this stock.

MACD and moving average data are not available for this stock.